Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$30.19 - $40.28 $150,950 - $201,400
-5,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$29.09 - $45.68 $145,450 - $228,400
5,000 New
5,000 $210,000
Q2 2018

Aug 14, 2018

SELL
$27.2 - $74.35 $1.05 Million - $2.87 Million
-38,569 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$24.05 - $37.5 $927,584 - $1.45 Million
38,569 New
38,569 $1.15 Million

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $386M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Crawford Lake Capital Management, LLC Portfolio

Follow Crawford Lake Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.